Gender difference in the characteristics of and high-risk behaviours among non-injecting heterosexual methamphetamine users in Qingdao, Shandong Province, China by Dianchang Liu et al.
Liu et al. BMC Public Health 2013, 13:30
http://www.biomedcentral.com/1471-2458/13/30RESEARCH ARTICLE Open AccessGender difference in the characteristics of and
high-risk behaviours among non-injecting
heterosexual methamphetamine users in
Qingdao, Shandong Province, China
Dianchang Liu1,3, Zhenhong Wang2, Tongsheng Chu1,3 and Shumin Chen1,3*Abstract
Background: Despite the increasing risk of HIV infections, few studies concerning the characteristics of non-injecting
heterosexual methamphetamine (MA) users and related risk behaviours have been conducted in China.
Methods: Gender differences in socio-demographic characteristics, perception of MA and STD/HIV, MA use
practices, and sexual behaviours related to MA use were examined among 398 non-injecting heterosexual MA
users (288 males, 110 females).
Results: Male MA users were more likely to be married, local, and self-employed; female MA users were more
likely to be young, single, engaged in commercial service or unemployed. Female MA users usually start MA
use at an earlier age than males (24.3 vs. 31.3 years old), with shorter abuse durations (2.6 vs. 2.9 years),
higher frequency of MA use (3.6 vs. 2.4 times per week), and higher likelihood of using MA with heterosexual
partners (100% vs. 78.1%). More male MA users have had multiple sex partners (96.9% vs. 77.3%) and sex
exchanges (72.9% vs. 46.4%). Among 277 males who had had sex with commercial sex workers (CSW), 69.4%
never used condoms, and among 77 males who had had sex with multiple partners who are commercial sex
workers and always or usually used condoms, 87.0% never changed condoms when changing partners.
Conclusion: There may be gender difference in the characteristics of high-risk behaviours among non-injecting
heterosexual MA users. The findings suggest the integration of specific risk reduction strategies into intervention
programs for non-injecting heterosexual MA user populations may significantly improve program goals.
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The use of amphetamine-type stimulants (ATS) includ-
ing methamphetamines (MA) is a growing global health
problem. ATS are the second most widely used group of
substances, among which MA is the most prominent. It
is estimated globally that the annual prevalence for ATS
ranged between 0.3% and 1.2% in 2010, or some 14 to
52 million people aged 15 years to 64 years who had
used such substances at least once in 2010 [1].* Correspondence: chenshm@public.jn.sd.cn
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reproduction in any medium, provided the orMany studies have addressed the physical and psycho-
logical harms of chronic MA use [2,3] and its association
with high-risk sexual behaviours among men who have
sex with men (MSM) [4,5]. MA use among MSM has
been associated with low rates of condom use, high rates
of unprotected anal sex, prolonged sexual activity, mul-
tiple partners, and casual partners [6-8]. Some studies
among female drug users have also shown MA use to be
associated with elevated concomitant sexual risks, in-
cluding a higher number of sexual partners, unprotected
vaginal and/or anal sex, and exchanging sex for money
or drugs [9-11]. Besides increasing high-risk sexual
behaviours, MA use can enhance HIV-1 infections in
human macrophages in vitro [12]. Many studies indicateThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(STDs) infections among different MA users [13-16].
China is one of two countries with the highest records
of ATS abuse. By the end of 2011, 1.794 million drug
users had been registered in the updated Drug Abusers
Information Database of China. Users of “new-type
drugs,” including ATS and ketamine, accounted for
32.7% of the total number of registered drug users [17].
Injection drug use (IDU), which mainly includes
heroin, used to be the major cause of HIV infections,
and the association between IDU and risk of HIV
infections has been well documented [18]. However,
the transmission routes of HIV have largely changed
in recent years. The proportion of cases resulting
from sexual transmission increased from 33.1% in
2006 to 76.3% in 2011 [19]. Compared with non-MA
users, non-injecting heterosexual MA users report
significantly higher numbers of sex partners, more
frequent engagements in anal sex, and less frequent
use of condoms and are twice as likely to have sex
with a commercial sex worker (CSW) or exchange
sex for drugs [7].
To date, despite the increasing risk for widespread
HIV infections, little attention has been given to non-
injecting heterosexual MA users, and the characteristics
of non-injecting heterosexual MA users and related
risk behaviours among them have not been well stud-
ied in China. A pilot study in Shandong Province
found an alarmingly high prevalence of MA use
among female CSWs. MA users were more likely to
be inconsistent in condom usage and have syphilis
[20]. The aim of this study is to explore the
characteristics of male and female non-injecting hetero-
sexual MA users in China and evaluate their high-risk
behaviours in order to find specific intervention measures
to prevent STDs and HIV infection.
Methods
Study site
The study was conducted in Chengyang District,
Qingdao, Shandong Province, China. Qingdao is a
coastal city in Shandong that attracts many foreign and
domestic investors and tourists because of its mild cli-
mate, convenient transportation, and favourable pol-
icies. However, accompanied by booms in economic
development and the entertainment industry, drug
trafficking and abuse have become increasingly com-
mon in the city over the last ten years. Famous for
“Iceland” in China (Qingdao is on the eastern end of
Shandong Peninsula, and MA looks like ice in appear-
ance), aside from having many MA users, Qingdao is
one of the distribution centres of MA from South
Korea, Japan, and Russia to China. Chengyang is one of
the suburban districts of Qingdao. It connects theurban and rural areas of northern Qingdao and has a
total area of 553.2 square kilometres and a population
of 0.76 million people, including a mobile population
of 0.3 million. It is one of the major industrial areas
in Qingdao and, for many years, has been among the
top districts in Shandong Province for exports. In the
district, there are many foreign-owned or joint enterprises,
manufacturing, and entertainment venues. MA users can
be found in nightclubs, KTVs (one kind of entertainment
venues with many private rooms where customers can
sing and dance by themselves), bars, bath centres, hotels,
and so on.
Recruitment and screening of participants
This study was conducted as part of the “AIDS
Projects in the Cover” program funded by the Bill &
Melinda Gates Foundation and the Chinese govern-
ment. Most participants were recruited from night-
clubs, KTVs, bars and bath centres, accounting for
22.3%, 30.5%, 30.3%, and 9.6%, respectively, of the
sample. Community outreach workers visited these
venues and made the acquaintance of potential study
subjects. The following inclusion criteria were used:
(1) self-identified heterosexual; (2) use of MA as a
major addictive drug; (3) use of MA by any means
aside from injection; (4) in the 1 month prior to
screening, had used MA at least once. A person sat-
isfying all of these criteria was asked for an interview
and examination at an STD clinic in the community
hospital the following day. The “Snow Ball” approach
was also applied in enrolling participants. Around
5.1% of the participants were recruited directly by doctors
at the STD clinic, and 2.3% were referred by bosses of en-
tertainment venues, friends, and STD clinical attendees.
All surveys and examinations were conducted at the STD
clinic in the community hospital by an STD doctor and a
nurse. Around 87.5% of the female participants were
CSWs; the remaining female participants were girlfriends
or casual sex partners of male participants.
Data collection
The research protocol was approved by the Ethical Com-
mittee of Shandong Provincial Hospital for Skin Diseases,
and all participants completed verbal informed consent
prior to participation. An interviewer-administered ques-
tionnaire was used in data collection (see Additional
file 1 for the questionnaire). The following characteristics
of MA users were examined: demographics (gender, age,
marital status, ethnicity, education, residency and em-
ployment); perception of MA; perception of STDs/HIV;
MA use; and sexual behaviour related to MA use. Each
topic area was covered by several variables, each in the
form of a question. Those diagnosed with STDs were
given free and appropriate treatments.
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The characteristics of MA users by gender were
examined. Differences in demographic characteristics,
perception of MA, perception of STDs/HIV, MA use, and
sexual behaviour related to MA use between males and




As shown in Table 1, among the 398 participants, 288
were males and 110 were females. The average age of
females was significantly lower than males (27.0 vs.
34.2 years old). Males were more likely to be married
(70.5% vs. 40.9%), while females were more likely to be
single (50.0% vs. 25.3%). Males were more likely to be
permanent residents (86.5% vs. 48.2%), while females
were more likely to be in the mobile population
(51.8% vs. 13.5%). Males were more likely to be self-
employed businessmen (73.3% vs. 11.8%), while females
were more likely to be engaged in commercial service
(56.6% vs. 4.9%) or unemployed (30.9% vs. 16.3%). All
of the differences between male and female MA users
were statistically significant (p<0.05). No significant
differences were observed in terms of ethnicity and
education level by gender, with Han accounting forTable 1 Demographic differences among 398 participants by
Variable Total (N=398) Male (N=28
Age, M (SD), range 32.3 (9.6), 16-67 34.2 (1.0), 16-
Marital status
Single, n (%) 128 (32.2) 73 (25.3)
Married, n (%) 256 (64.3) 203 (70.5)
Divorced, n (%) 14 (3.5) 12 (4.2)
Ethnicity
Han, n (%) 353 (88.7) 262 (91.0)
Korean, n (%) 26 (6.5) 14 (4.9)
Others, n (%) 19(4.8) 12 (4.2)
Education
Elementary school, n (%) 18 (4.5) 15 (5.2)
Middle school, n (%) 276 (69.3) 201 (69.8)
High/technical school, n (%) 92 (23.1) 64 (22.2)
College or above, n (%) 12 (3.0) 8 (2.8)
Residency
Permanent residents, n (%) 302 (75.9) 249 (86.5)
Mobile population, n (%) 96 (24.1) 39 (13.5)
Employment
Self-employed, n (%) 224 (56.3) 211 (73.3)
Commercial service, n (%) 76 (19.1) 14 (4.9)
Unemployed, n (%) 81 (20.4) 47 (16.3)
Others, n (%) 17 (4.3) 16 (5.6)88.7% and middle school education accounting for 69.3%
of the sample, respectively.
Perception of MA use
As shown in Table 2, 92.2% of the respondents
considered MA use as common as smoking and this per-
ception was more acceptable in males than in females
(96.2% vs. 81.8%, p<0.05). Most males and females
believed that MA enhances sexuality (97.2% vs. 99.1%,
p>0.05) while more males than females believed that it
helps promote anti-inebriation (63.9% vs. 37.3%, p<0.05)
and pain relief (44.1% vs. 33.6%, p<0.05). No gender
differences were found in terms of perception of
addictiveness of MA (47.2% vs. 44.5%, p>0.05) and pro-
portion of self-reported addiction to MA (46.2% vs.
43.6%, p>0.05). Among those who admitted MA addic-
tion, 30.1% of the males responded that it had occurred
to them to abstain from MA and wanted to try it. In
comparison, 33.3% of the females responded that it had
occurred to them to abstain from MA but only 8.3% of
them wanted to try it (p<0.05).
Perception of STDs/AIDS
As shown in Table 3, 99.7% of the males and 100% of
the females had heard of syphilis (p>0.05). The propor-
tion of those who claimed knowing the transmissiongender
8) Female (N=110) t X2 P value
67 27.0 (6.3), 19-48 7.11 <0.05
55 (50.0) 38.302 <0.05
53 (40.9)
2 (9.1)
91 (82.7) 5.772 >0.05
12 (10.9)
7 (6.4)




53 (48.2) 63.717 <0.05
57 (51.8)




Table 2 Perceptions of MA use among MA users
Questions Total (%, N=398) Male (%, N=288) Female (%, N=110) X2 P value
Do you think MA use is as common as smoking? (Yes) 367 (92.2) 277 (96.2) 90 (81.8) 22.861 <0.05
Can MA enhance sexuality? (Yes) 389 (97.7) 280 (97.2) 109 (99.1) >0.05
Does MA have the function of anti-inebriation? (Yes) 225 (56.5) 184 (63.9) 41 (37.3) 34.120 <0.05
Can MA relieve pain? (Yes) 164 (41.2) 127 (44.1) 37 (33.6) 13.287 <0.05
Is MA addictive? (Yes) 185 (46.5) 136 (47.2) 49 (44.5) 0.229 >0.05
Are you addicted to MA? (Yes) 181 (45.5) 133 (46.2) 48 (43.6) 0.208 >0.05
Did it occur to you to abstain from MA? (Yes) 56/181(30.9) 40/133 (30.1) 16/48 (33.3) 0.157 >0.05
Do you want to have a try to abstain from MA? (Yes) 44/181(24.3) 40/133 (30.1) 4/48 (8.3) 9.061 <0.05
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(93.1% vs. 77.3%, p<0.05). Although as high as 99.3% of
the males and 100% of the females reported knowing the
transmission routes of HIV, 64.2% of the males and
84.5% of the females believed that HIV can be transmit-
ted by eating together (p>0.05). Approximately 97.2% of
the males and 100% of the females knew the risk of mul-
tiple sex partners. However, 33.3% of the males and
29.1% of the females believed that an HIV-infected per-
son could be identified by appearance, and only 52.4% of
the males and 67.3% of the females believed that STDs/
AIDS could be prevented by using condoms (p<0.05).Behaviours of MA use
As shown in Table 4, most of the male and female
respondents reported MA as the only drug they used
(94.8% vs. 98.2%, p>0.05). Both the average onset age
and the average years of MA use among females were
lower than those among males (24.3 vs. 31.3, p<0.05; 2.6
vs. 2.9, p<0.05), and more females started MA use at an
early age (X2=62.170, p<0.05) with a shorter period of
use (X2=19.411, p<0.05) than males. However the aver-
age times of MA use per week was higher among
females than among males (3.6 vs. 2.4, p<0.05), and the
proportion of those who used MA an average of 5 times
and above per week was much higher in females than in
males (X2=89.468, p<0.05). MA was usually used in
groups, and the group size reported by males was larger
than that reported by females (4.2 vs. 3.8 persons,Table 3 Perceptions of STD/AIDS among MA users
Questions Total (%, n=398
Have you ever heard of syphilis? (Yes) 397 (99.7)
Do you know the transmission routes of syphilis? (Yes) 353 (88.7)
Do you know the transmission routes of HIV? (Yes) 396 (99.5)
Can HIV be transmitted by eating together? (Yes) 278 (69.8)
Do you know the risk of multiple sex partners? (Yes) 390 (98.0)
Can HIV infection be identified by appearance? (Yes) 128 (32.2)
Can STD/AIDS be prevented by using condom? (Yes) 225 (56.5)p<0.05). Females were more likely to use MA with het-
erosexual partners than males (100% vs. 78.1%, p<0.05).
High-risk sexual behaviours related to MA use
As shown in Table 5, the proportions in males who had
had sex with multiple partners and exchanged sex
partners during MA use was significantly higher than
those in females (96.9% vs. 77.3%, X2=39.147, p<0.05;
72.9% vs. 46.4%, X2=24.862, p<0.05). Among 288 male
respondents, 96.2% had had sex with CSWs during MA
use, and the number of CSWs as sex partners per MA
use was 1.9 persons. Among 277 males who had had sex
with CSWs, 72.2% had never used condoms. Among 77
males who had had sex with multiple CSW partners and
reported always or usually using condoms, 87.0% had
never changed condoms when changing CSW partners.
About 96.4% of the females reported having had sex
with partners for MA or money.
Discussion
Gender differences among MA users have been reported
by some studies. Female MA users were more likely to be
younger, have lower educational level, have never been
married, and be an MA-using sex partner [21-23]. Our
findings show significant differences between the demo-
graphic characteristics of male and female MA users, and
some new findings in this study differed from those in
other studies. Most male MA users in this study were mar-
ried and local or self-employed businessmen; most female) Male (%, n=288) Female (%, n=110) X2 P value
287 (99.7) 110 (100)
268 (93.1) 85 (77.3) 19.772 <0.05
286 (99.3) 110 (100)
185 (64.2) 93 (84.5) 17.978 <0.05
280 (97.2) 110 (100) >0.05
96 (33.3) 32 (29.1) 1.262 >0.05
151 (52.4) 74 (67.3) 17.800 <0.05
Table 4 MA use behaviours among MA users
Variable Total (N=398) Male (N=288) Female (N=110) t X2 P value
Using MA only, n (%) 381 (95.7) 273 (94.8) 108 (98.2) >0.05
Onset age of MA use, M (SD), range 29.4 (9.1), 16-62 31.3 (9.3), 16-67 24.3 (6.2), 17-44 7.367 <0.05
<20 years old 42 (10.6) 13 (4.5) 29 (26.4)
20~29 years old 174 (43.5) 116 (40.3) 58 (52.7) 62.170 <0.05
30~39 years old 120 (29.9) 100 (34.7) 20 (18.2)
≥40 years old 62 (16.1) 59 (20.5) 3 (2.7)
Years of MA use, M (SD), range 2.8 (1.1), 1-8 2.9 (1.2), 1-8 2.6 (0.9), 1-5 2.650 <0.05
1 year 42 (10.6) 34 (11.8) 8 (7.3)
2 years 127 (31.9) 75 (26.0) 52 (47.3)
3 years 128 (32.2) 96 (33.3) 32 (29.1) 19.411 <0.05
4 years 71 (17.8) 56 (19.4) 15 (13.6)
≥5 years 30 (7.5) 27 (9.4) 3 (2.7)
Times of MA use per week, M (SD), range 2.8 (1.4), 1-7 2.4 (1.0), 1-6 3.6 (1.9), 1-7 8.270 <0.05
1 time 44 (11.1) 33 (11.5) 11 (10.0)
2 times 183 (46.0) 150 (52.1) 33 (30.0)
3 times 74 (18.6) 62 (21.5) 12 (10.9) 89.468 <0.05
4 times 53 (13.3) 37 (12.8) 16 (14.5)
≥5 times 44 (11.1) 6 (2.1) 38 (34.5)
Number of persons using MA together (SD), range 4.1 (1.6), 2-10 4.2 (1.4), 2-10 3.8 (1.9), 2-10 2.409 <0.05
Always using MA with heterosexual partners, n (%) 335 (84.2) 225 (78.1) 110 (100) 28.588 <0.05
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findings are interesting because they suggest that gender-
specific intervention measures should be implemented in
risk reduction programs for MA user populations.
The reasons for MA use were investigated in this survey.
The major reason for MA use is its benefit in enhancing
sexuality; most male and female respondents neglected its
addictiveness. Furthermore, both males and females had
several wrong perceptions of MA. MA was usually
regarded as a daily life necessity, very much like cigarettes,
especially by male respondents. This finding indicates thatTable 5 High-risk sexual behaviours related to MA use among
Variable Total (n=39
Had sex with multiple partners during MA use 364 (91.5)
Exchanged sex partners during MA use 261 (65.6)
Had sex with commercial sex workers(CSWs) during MA use
Number of CSWs as sex partners per MA use, M (SD), range




Changing condoms when changing CSWs
Never
Usually
Alwaysmore information on the risks and harm of MA should be
provided in intervention programs in the future. MA use is
a complicated social problem in many countries. The
reasons why more and more people fall into MA addiction
require more studies from the physiological, psychological,
and social perspectives. Individual, social, and environmen-
tal factors have been reported to be associated with initiat-
ing MA injection [24]. In this study, among those who
recognised its addictiveness, fewer females than males
wanted to try to abstain from MA. The reasons underlying
this behaviour require further investigation.MA users
8) Male (n=288) Female (n=110) t X2 P value
279 (96.9) 85 (77.3) 39.147 p<0.001
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behaviours. Most female MA users initiated MA use at
an early age, had shorter abuse durations, used MA more
frequently, and were more likely use MA with heterosex-
ual partners. MA enhances sexual performance, sensitiv-
ity, and pleasure, increasing the risk of trauma from
prolonged intercourse and failure to use condoms [25,26],
and is associated with having multiple sex partners and
unprotected sex [9-11]. Results from this paper support
previous findings showing that MA use can greatly in-
crease the risk of STD/HIV transmission. Although most
respondents in this study had enough knowledge of STD/
AIDS, some misunderstandings were observed. Most male
and female respondents recognised the risk of multiple
sex partners; however, many MA users did not know how
to prevent STDs/AIDS using condoms. High-risk sexual
behaviours related to MA use among these respondents
were very common, including having sex with multiple
partners and exchanging sex partners. More males had
been engaged in group sex and sex partner exchanges
than females because most male respondents had had sex
with CSWs during MA use. It indicates the truth that
many sex episodes involved one man and more than one
woman including those women who are not MA users
during MA use, suggesting that some form of intervention
specific to these kinds of sex encounters should be
conducted. Furthermore, many males had also been
engaged in other high-risk sexual practices, such as never
using condoms and never changing condoms when chan-
ging CSW partners, which may endanger their female
partners as well.
Several limitations are present in this study, including
the sample population and the data collection methods.
First, the study utilised non-random sampling recruit-
ment methods and had inclusion criteria confined to
non-injected heterosexual MA users; thus, the generalis-
ability of the study results could be limited. Second, be-
havioural data were collected through self-reporting and
memory or recall of behaviours during sexual or MA
use events may be problematic. Third, most female MA
users recruited into the study report behaviors that
would lead them to be classified as sex workers. There-
fore, the sample tells us little about MA use and related
knowledge, attitudes, and risk behaviors in the broader
population of women who use MA without injection. Fi-
nally, although STD/HIV testing was conducted for each
participant in this cross-sectional study, detailed infor-
mation about actual STD/HIV infection rates in this art-
icle was not provided. A multi-factor analysis on STD/
HIV prevalence among non-injecting heterosexual MA
users will be conducted in another study.
The study was characterised by a number of
strengths. First, this study provides the first report in
China addressing the characteristics of and high-riskbehaviours among non-injecting heterosexual MA users.
Second, the findings enrich our knowledge of gender
differences in demographic characteristics, perception of
MA and STDs/HIV, and high-risk behaviours among
non-injecting heterosexual MA users. Third, this study
discussed the reasons for MA use, although further
investigation is needed.
Conclusion
In conclusion, gender differences in the characteristics
of and high-risk behaviours among non-injecting hetero-
sexual MA users were observed. The findings suggest
that integrating specific risk reduction strategies for
non-injecting heterosexual MA user populations into
intervention programs will be beneficial to the success
of such programs.
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